secwatch / observer

8-K filed March 2, 2026, 6:59 PM ET ticker ONCY CIK 0001129928

other material confidence high sentiment positive materiality 0.65

Oncolytics launches Phase 2 REO 033 trial in 2L RAS-mutant MSS mCRC; preliminary data expected by end of 2026

ONCOLYTICS BIOTECH INC

Randomized Phase 2 study (REO 033) of pelareorep + bevacizumab + FOLFIRI vs bevacizumab + FOLFIRI in 30 patients per arm.
Primary endpoint is ORR; secondary endpoints include PFS, OS, safety, and biomarker analysis; first site expected this month.
Prior REO 022 study showed median OS 27 months and PFS 16.6 months, vs 11.2 and 5.7 months for standard of care.
Pelareorep combination recently granted FDA Fast Track Designation for this indication.
Lead investigator is Dr. Sanjay Goel (Rutgers Cancer Institute); preliminary data by year-end 2026.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001129928-26-000009
form_type: 8-K
ticker: ONCY
cik: 0001129928
company_name: ONCOLYTICS BIOTECH INC
filed_at: 2026-03-02T23:59:59+00:00
discovered_at: 2026-05-14T18:02:34.594547+00:00
generated_at: 2026-05-15T22:36:31.789042+00:00
sec_items: ["8.01", "9.01"]
event_type: other_material
sentiment: positive
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001129928-26-000009
json_url: https://secwatch.observer/filing/0001129928-26-000009.json
markdown_url: https://secwatch.observer/filing/0001129928-26-000009.md
text_url: https://secwatch.observer/filing/0001129928-26-000009.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1129928/000112992826000009/0001129928-26-000009-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1129928/000112992826000009/oncy-20260302.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

MBOT

Microbot Medical secures first North Carolina customer for LIBERTY robotic system

Microbot Medical Inc. June 2, 2026, 8:30 AM ET other_material Items 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

SAIA

Saia reports April/May LTL shipments up 5.6%/3.7%, tonnage up 6.9%/8.4% YoY

SAIA INC June 2, 2026, 7:45 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

FLGT

Fulgent Genetics reports encouraging Phase 2 data for FID-007 in HNSCC at ASCO 2026

Fulgent Genetics, Inc. June 1, 2026, 7:07 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

KRMN

Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds

Karman Holdings Inc. June 1, 2026, 5:28 PM ET other_material Items 1.01, 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

GIPR

Generation Income Properties prices $5.0M public offering of 23.8M shares and warrants at $0.21/unit

GENERATION INCOME PROPERTIES, INC. June 1, 2026, 5:27 PM ET other_material Items 1.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

PECE

Peace Acquisition Corp closes IPO of 6M units at $10.00/unit, raising $60M

Peace Acquisition Corp. June 1, 2026, 5:16 PM ET other_material Items 3.02, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

MUX

McEwen receives $49.4M dividend from Minera Santa Cruz; total 2026 dividends now $58.2M

McEwen Inc. June 1, 2026, 5:14 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

MVIS

MicroVision seeks reverse stock split approval; ratio 1:5 to 1:15; annual meeting July 10, 2026

MICROVISION, INC. June 1, 2026, 5:02 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001129928-26-000009

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.